QUEBEC CITY, Aug. 8, 2012 /PRNewswire/ - Aeterna Zentaris Inc.
(NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its
second quarter 2012 financial and operating results after market
close on Tuesday, August 14, 2012.
The Company will host a conference call on the following day,
Wednesday, August 15, 2012, at
8:30 a.m. (Eastern Time), to discuss
these results, provide an update on the Company's business and
discuss expectations for the future.
Participants may access the live webcast via the Company's
website at www.aezsinc.com in the "Newsroom" section, or by
telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside
Canada, 888-231-8191. A replay of
the webcast will also be available on the Company's website for a
period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug
development company currently investigating treatments for various
unmet medical needs. The Company's pipeline encompasses compounds
at all stages of development, from drug discovery through to
marketed products. For more information, please visit
www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.